Literature DB >> 11781987

Feasibility of partial nephrectomy for Wilms' tumor in children with Beckwith-Wiedemann syndrome who have been screened with abdominal ultrasonography.

D Elizabeth McNeil1, Jacob C Langer, Peter Choyke, Michael R DeBaun.   

Abstract

BACKGROUND: Children with Beckwith-Wiedemann syndrome (BWS), a congenital syndrome associated with Wilms' tumor commonly are screened with abdominal sonography resulting in detection of tumor at a lower stage. Wilms' tumors have been traditionally treated with complete nephrectomy; however, smaller tumors are amenable to nephron-sparing surgery. Because Wilms' tumors may be metachronous and nonmalignant disease may compromise renal function in BWS, nephron-sparing approaches may be desirable as the first option.
METHODS: Seven patients with BWS and Wilms' tumor underwent nephrectomy. The preoperative computed tomography (CT) or ultrasound scan were evaluated by a pediatric surgeon to assess whether partial nephrectomy would have been feasible. The determining criteria included tumor involving one third or less of the kidney and no involvement of either hilar or vascular structures.
RESULTS: Seven patients underwent complete nephrectomies. The remaining patient, who had undergone a left nephrectomy before the initiation of screening had salvage chemotherapy after biopsy results showed right kidney involvement with Wilms' tumor.
CONCLUSIONS: Nephron-sparing surgery is reasonable to consider in children with Beckwith-Wiedemann syndrome who are screened at intervals of 4 months or less. The relative benefits of partial nephrectomy for children with Wilms' tumor-predisposing conditions only can be assessed in the setting of a cooperative clinical trial. Copyright 2002 by W.B. Saunders Company.

Entities:  

Mesh:

Year:  2002        PMID: 11781987     DOI: 10.1053/jpsu.2002.29427

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Nephrological findings and genotype-phenotype correlation in Beckwith-Wiedemann syndrome.

Authors:  Alessandro Mussa; Licia Peruzzi; Nicoletta Chiesa; Agostina De Crescenzo; Silvia Russo; Daniela Melis; Luigi Tarani; Giuseppina Baldassarre; Lidia Larizza; Andrea Riccio; Margherita Silengo; Giovanni Battista Ferrero
Journal:  Pediatr Nephrol       Date:  2011-10-21       Impact factor: 3.714

2.  Reply to Brioude et al.

Authors:  Jack Brzezinski; Cheryl Shuman; Sanaa Choufani; Peter Ray; Dimitri J Stavropoulos; Raveen Basran; Leslie Steele; Nicole Parkinson; Ronald Grant; Paul Thorner; Armando Lorenzo; Rosanna Weksberg
Journal:  Eur J Hum Genet       Date:  2018-02-15       Impact factor: 4.246

3.  Therapeutic results in stage I Wilms' tumors in children - 15 years of surgical experience.

Authors:  Sabina Szymik-Kantorowicz; Wiesław Urbanowicz; Marcin Surmiak; Janusz Sulisławski
Journal:  Cent European J Urol       Date:  2012-09-04

4.  Prenatal correction of IGF2 to rescue the growth phenotypes in mouse models of Beckwith-Wiedemann and Silver-Russell syndromes.

Authors:  Ji Liao; Tie-Bo Zeng; Nicholas Pierce; Diana A Tran; Purnima Singh; Jeffrey R Mann; Piroska E Szabó
Journal:  Cell Rep       Date:  2021-02-09       Impact factor: 9.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.